§ PHARMACEUTICALS
USD · PharmaceuticalsPHVS
PHARVARIS NV
USDSector · Pharmaceuticals
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| GENERAL ATLANTIC, L.P. | 8.0M | 10.6% | ±0% |
| Foresite Capital Management IV, LLC | 4.8M | 56.9% | ±0% |
| venBio Partners LLC | 4.6M | 46.7% | ±0% |
| Fidelity Management | 4.5M | 0.0% | −2% |
| Two Sigma | 3.7M | 0.3% | ±0% |
| EQT Fund Management S.a r.l. | 3.4M | 9.5% | ±0% |
◇ AC INTELLIGENCE
Top institutional owners for PHVS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER7.4% · 0 holders
OTHER72.0% · 74 holders
QUALITY / COMPOUNDER10.2% · 6 holders
TACTICAL / MACRO7.0% · 5 holders
PASSIVE / INDEX1.4% · 3 holders
DEALER / BANK1.1% · 14 holders
ACTIVIST0.5% · 1 holder
SYSTEMATIC / QUANT0.2% · 3 holders
INCOME / DEFENSIVE0.1% · 5 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for PHVS in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention PHVS yet.